Literature DB >> 15713269

Interleukin-1beta enhances NMDA receptor-mediated current but inhibits excitatory synaptic transmission.

Sheng Yang1, Zhen-Wei Liu, Lei Wen, Hai-Fa Qiao, Wen-Xia Zhou, Yong-Xiang Zhang.   

Abstract

Interleukin (IL)-1beta is often characterized as the prototypic proinflammatory cytokine but is involved in various pathophysiological conditions in the central nervous system (CNS). A whole-cell recording technique was used to observe its effect on N-methyl-D-aspartate (NMDA)-evoked currents and spontaneous synaptic activity in cultured rat hippocampal neurons. The results showed that the frequencies but not the amplitudes of spontaneous excitatory postsynaptic currents (sEPSC) and miniature excitatory postsynaptic currents (mEPSC) were decreased by 10 or 100 ng/ml IL-1beta. IL-1beta at these concentrations also increased the NMDA receptor-mediated current. In addition, 10 ng/ml IL-1beta significantly increased the amplitude of the voltage-dependent Ca2+ current (I(Ca)). The increase in I(Ca) following treatment of cultures with IL-1beta resulted mainly from an increase in L-type current. These data suggest that IL-1beta modulates hippocampus-related functions via its effect on synaptic activity and Ca2+ signaling in neurons.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15713269     DOI: 10.1016/j.brainres.2004.11.018

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  39 in total

Review 1.  Mode of action of cytokines on nociceptive neurons.

Authors:  Nurcan Uçeyler; Maria Schäfers; Claudia Sommer
Journal:  Exp Brain Res       Date:  2009-03-17       Impact factor: 1.972

2.  Humanin attenuated the change of voltage-dependent potassium currents in hippocampal neurons induced by anoxia.

Authors:  Wei Liu; Xin-Ping Zhang; De-Li Yang; Shu-Wei Song
Journal:  CNS Neurosci Ther       Date:  2013-12-03       Impact factor: 5.243

Review 3.  Puberty and adolescence as a time of vulnerability to stressors that alter neurobehavioral processes.

Authors:  Mary K Holder; Jeffrey D Blaustein
Journal:  Front Neuroendocrinol       Date:  2013-11-01       Impact factor: 8.606

Review 4.  IL-1β: an important cytokine associated with febrile seizures?

Authors:  Hong-Mei Yu; Wan-Hong Liu; Xiao-Hua He; Bi-Wen Peng
Journal:  Neurosci Bull       Date:  2012-06       Impact factor: 5.203

5.  Role of interleukin-10 (IL-10) in regulation of GABAergic transmission and acute response to ethanol.

Authors:  A Suryanarayanan; J M Carter; J D Landin; A L Morrow; D F Werner; I Spigelman
Journal:  Neuropharmacology       Date:  2016-03-22       Impact factor: 5.250

6.  Peripherally restricted viral challenge elevates extracellular glutamate and enhances synaptic transmission in the hippocampus.

Authors:  Holly C Hunsberger; Desheng Wang; Tiffany J Petrisko; Ahmad Alhowail; Sharay E Setti; Vishnu Suppiramaniam; Gregory W Konat; Miranda N Reed
Journal:  J Neurochem       Date:  2016-06-03       Impact factor: 5.372

Review 7.  The role of trigeminal interpolaris-caudalis transition zone in persistent orofacial pain.

Authors:  Ke Ren; Ronald Dubner
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

8.  Microinjection of IL-1β into the trigeminal transition zone produces bilateral NMDA receptor-dependent orofacial hyperalgesia involving descending circuitry.

Authors:  K Shimizu; Bryan Chai; Stacey C Lagraize; F Wei; R Dubner; K Ren
Journal:  Open Pain J       Date:  2009-01-01

Review 9.  Neuron-glia crosstalk gets serious: role in pain hypersensitivity.

Authors:  Ke Ren; Ronald Dubner
Journal:  Curr Opin Anaesthesiol       Date:  2008-10       Impact factor: 2.706

10.  Neurodevelopmental effects of chronic exposure to elevated levels of pro-inflammatory cytokines in a developing visual system.

Authors:  Ryan H Lee; Elizabeth A Mills; Neil Schwartz; Mark R Bell; Katherine E Deeg; Edward S Ruthazer; Nicholas Marsh-Armstrong; Carlos D Aizenman
Journal:  Neural Dev       Date:  2010-01-12       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.